Tyche Industries — 360° view

Tyche Industries, a company in the Pharmaceuticals industry, reported revenue of ₹14 crore and net profit of ₹1.14 crore for the September 2026 quarter.

Tyche Industries (BSE: TYCHE) closed at ₹103.79 on 20 Nov 2026, down 14.2% over the past year. Its market capitalisation is ₹106 crore and it trades at 26.1 times earnings.

Share price
₹103.79 (20 Nov 2026)
Market cap
₹106 Cr (20 Nov 2026)
P/E
26.14 (20 Nov 2026)
Revenue
₹14 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
6.83% (FY26)
ROE
5.01% (FY26)
Book value
₹138 (FY26)
Dividend yield
3.37% (FY26)
52-week high / low
₹148.00 / ₹98.00 (20 Nov 2026)
1-year return
-14.2% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: TYCHE

Incorporated in 1998, Tyche Industries Ltd does manufacturing of active pharmaceutical ingredients

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.